Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
Pharma stocks are gaining momentum as obesity drugs, oncology therapies and biotech innovation boost investor optimism.
UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on transforming the treatment of urothelial and specialty cancers, today announced UGN-103 achieved a 94.5% (95% CI: 86.1, 97.9) ...
19hon MSN
Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of ...
AllAfrica on MSN
Benue, with Nigeria's heaviest HIV treatment burden, launches long-acting prevention drug
The Benue State Government has launched Lenacapavir, a long-acting injectable drug for HIV prevention, as part of efforts to curb new infections and end AIDS by 2030.The Benue State Government has ...
The trial did not reach statistical significance for the primary endpoint of improvement in progression-free survival (PFS) A numeric improvement of 5.1 months in median PFS was observed for the high- ...
Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...
Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results